Trial Profile
Monocentric prospective randomized controlled open phase IV study to explorate the mechanismen of the synergetic effect of the Crateagus -Extract WS 1442 in addition to endurance training related to quality of life of patients with limited physical potential caused by cardiovascular disease (Heart Failure Stade NYHA II).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2014
Price :
$35
*
At a glance
- Drugs Crataegus (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Sponsors Dr. Willmar Schwabe Pharmaceuticals
- 12 Jul 2012 Additional trial identifier 2009-111 identified as reported by German Clinical Trials Register.
- 25 Aug 2011 New source identified and integrated (German Clinical Trials Register DRKS00000259).
- 25 Aug 2011 Status changed from recruiting to completed as reported by German Clinical Trials Register